The purpose of this study is to evaluate the efficacy and safety of ION582 in children and adults with Angelman syndrome caused by a deletion or mutation of the UBE3A gene.
Age: 2 - 50 years
Gender: All
We've found 1 total result for "Angelman Syndrome".